Skip to main content

Year in review · from our October 2026 register copy

NAFDAC registrations in 2022

By the approval dates our October 2026 copy of the Greenbook records, 538 products were approved onto the register in 2022 — 242 of them in Drugs. 98% of the class of 2022 is still active in our copy today.

By category

Month by month

Approvals are batched — quiet months and spikes are the register's own rhythm, not demand.

Jan
68
Feb
5
Mar
22
Apr
31
May
63
Jun
7
Jul
0
Aug
77
Sep
62
Oct
66
Nov
73
Dec
64

Who registered the most

  1. 1.Roche Products— 20 approvals
  2. 2.Krishat Pharma Industries— 14 approvals
  3. 3.Crystal-Uch Nigeria— 11 approvals
  4. 4.Century Industrial FZE— 10 approvals
  5. 5.Chupet Pharmaceutical— 10 approvals
  6. 6.Fouani Nigeria— 10 approvals
  7. 7.Hayat Kimya Nigeria— 10 approvals
  8. 8.Jawa International— 10 approvals
  9. 9.Emzor Pharmaceutical Industries— 9 approvals
  10. 10.Kcssa West Africa— 9 approvals

Where the year's medicines were made

Factory countries recorded on 242 of the year's 242 drug approvals.

Month-to-month changes — new listings, renewals, lapses — live on the NAFDAC Registry Watch, updated with every register refresh.

Other years

Counted from the approval dates in our dated copy of the public NAFDAC Greenbook. The register backfills approval entries long after the fact, so a year's count can still grow after it ends — which is also why the current year has no page until it completes. Registration counts are not market share or sales.